
What We're Reading: Drug Makers Take Cautious Approach on Off-Label Promotion
What we're reading, January 2, 2017: drug makers are taking a cautious approach to off-label promotion; Republicans eye changes to Medicaid under Trump administration; and the impact of geography on health.
Almost a year ago, a court ruling may have opened the gate for drug makers to promote off-label uses for medications, but most companies are playing it safe, for now.
Republicans are planning a lot of changes for healthcare under the Trump administration. In addition to repealing and replacing the Affordable Care Act and weighing a possible privatization of veterans’ medical care, the GOP is eyeing an overhaul to Medicaid,
Where a person lives can have a big impact on his or her health. A recent report highlighted how much of an impact geography can have with the finding that people in Mississippi live to 75, on average, while people in Hawaii can live longer than 81 years.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.